Marc Heijn

776 total citations
16 papers, 672 citations indexed

About

Marc Heijn is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Marc Heijn has authored 16 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Pediatrics, Perinatology and Child Health and 3 papers in Molecular Biology. Recurrent topics in Marc Heijn's work include Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Neonatal Health and Biochemistry (6 papers). Marc Heijn is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Neonatal Health and Biochemistry (6 papers). Marc Heijn collaborates with scholars based in Netherlands, Hungary and United States. Marc Heijn's co-authors include Jan Hendrik Hooijberg, J. Lankelma, Ronald P.J. Oude Elferink, George L. Scheffer, P. L. M. Jansen, H. M. Pinedo, HJ Broxterman, Hans V. Westerhoff, Jan Lankelma and Henk J. Broxterman and has published in prestigious journals such as Hepatology, JNCI Journal of the National Cancer Institute and Analytical Biochemistry.

In The Last Decade

Marc Heijn

16 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Heijn Netherlands 12 526 236 198 87 75 16 672
Kumie Kage Japan 6 606 1.2× 310 1.3× 218 1.1× 126 1.4× 101 1.3× 7 802
Kazuhiro Kagotani Japan 10 407 0.8× 278 1.2× 184 0.9× 122 1.4× 55 0.7× 16 646
Eiji Hinoshita Japan 9 514 1.0× 276 1.2× 142 0.7× 183 2.1× 47 0.6× 11 709
S. Percy Ivy United States 13 527 1.0× 452 1.9× 107 0.5× 75 0.9× 43 0.6× 18 868
Tanya Bagrij United Kingdom 8 349 0.7× 141 0.6× 145 0.7× 64 0.7× 48 0.6× 11 433
Alfons C. Wouterse Netherlands 12 286 0.5× 267 1.1× 176 0.9× 62 0.7× 46 0.6× 30 659
C. H. M. Versantvoort Netherlands 11 848 1.6× 411 1.7× 307 1.6× 175 2.0× 90 1.2× 14 992
Yasumasa Honjo United States 8 581 1.1× 249 1.1× 219 1.1× 106 1.2× 97 1.3× 11 700
Dorina M. van der Kolk Netherlands 16 591 1.1× 351 1.5× 193 1.0× 132 1.5× 42 0.6× 21 943
Csilla Özvegy Hungary 7 541 1.0× 264 1.1× 177 0.9× 133 1.5× 110 1.5× 8 619

Countries citing papers authored by Marc Heijn

Since Specialization
Citations

This map shows the geographic impact of Marc Heijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Heijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Heijn more than expected).

Fields of papers citing papers by Marc Heijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Heijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Heijn. The network helps show where Marc Heijn may publish in the future.

Co-authorship network of co-authors of Marc Heijn

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Heijn. A scholar is included among the top collaborators of Marc Heijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Heijn. Marc Heijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hassan, Mohamed, Marc Heijn, Martijn J. W. E. Rabelink, et al.. (2003). The protective effect of cardiac gene transfer of CuZn–sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells. Cancer Gene Therapy. 10(4). 270–277. 9 indexed citations
2.
Hensbergen, Yvette van, Henk J. Broxterman, Yvonne W. Elderkamp, et al.. (2002). A doxorubicin–CNGRC-peptide conjugate with prodrug properties. Biochemical Pharmacology. 63(5). 897–908. 70 indexed citations
3.
Scheffer, George L., Marcel Kool, Marc Heijn, et al.. (2000). Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.. PubMed. 60(18). 5269–77. 183 indexed citations
4.
Hooijberg, Jan Hendrik, H J Broxterman, George L. Scheffer, et al.. (1999). Potent interaction of flavopiridol with MRP1. British Journal of Cancer. 81(2). 269–276. 72 indexed citations
5.
Heijn, Marc, Sylvie Roberge, & R K Jain. (1999). Cellular membrane permeability of anthracyclines does not correlate with their delivery in a tissue-isolated tumor.. PubMed. 59(17). 4458–63. 15 indexed citations
6.
Wielinga, Peter R., Marc Heijn, Hans V. Westerhoff, & Jan Lankelma. (1998). A Method for Studying Plasma Membrane Transport with Intact Cells Using Computerized Fluorometry. Analytical Biochemistry. 263(2). 221–231. 14 indexed citations
7.
Heijn, Marc, Jan Hendrik Hooijberg, George L. Scheffer, et al.. (1997). Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1326(1). 12–22. 58 indexed citations
8.
Wielinga, Peter R., Marc Heijn, Henk J. Broxterman, & J. Lankelma. (1997). P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells. Biochemical Pharmacology. 54(7). 791–799. 11 indexed citations
9.
Hooijberg, Jan Hendrik, et al.. (1997). Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Letters. 413(2). 344–348. 90 indexed citations
10.
Broxterman, Henk J., Marc Heijn, & Jan Lankelma. (1996). Re: How Does the MRP/GS-X Pump Export Doxorubicin?. JNCI Journal of the National Cancer Institute. 88(7). 466–467. 5 indexed citations
11.
Roelofsen, Han, et al.. (1995). Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes. Hepatology. 21(6). 1649–1657. 6 indexed citations
12.
Elferink, Ronald P.J. Oude, Conny Bakker, Han Roelofsen, et al.. (1993). Accumulation of organic anion in intracellular vesicles of cultured rat hepatocytes is mediated by the canalicular multispecific organic anion transporter. Hepatology. 17(3). 434–444. 14 indexed citations
13.
Bakker, Conny, Han Roelofsen, Esther Middelkoop, et al.. (1993). Accumulation of organic anion in intracellular vesicles of cultured rat hepatocytes is mediated by the canalicular multispecific organic anion transporter.. PubMed. 17(3). 434–44. 49 indexed citations
14.
Heijn, Marc, Ronald P.J. Oude Elferink, & P. L. M. Jansen. (1992). ATP-dependent multispecific organic anion transport system in rat erythrocyte membrane vesicles. American Journal of Physiology-Cell Physiology. 262(1). C104–C110. 50 indexed citations
15.
Rüssel, Frans G. M., et al.. (1991). Effect of substituted benzoates on p-aminohippurate transport in dog renal membrane vesicles. Naunyn-Schmiedeberg s Archives of Pharmacology. 343(1). 102–107. 4 indexed citations
16.
Rüssel, Frans G. M., et al.. (1988). Na+ and h+ gradient-dependent transport of p-aminohippurate in membrane vesicles from dog kidney cortex. Biochemical Pharmacology. 37(13). 2639–2649. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026